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Abstract
Background: Cerebral involvement in schistosomiasis is not rare, but it is underdiagnosed because of the lack of
clinical suspicion and the frequency of asymptomatic forms. Neurologic complications are generally supported by
granuloma formation around ectopic eggs which have migrated to the brain. Moreover, vascular lesions and
cerebral arteritis have been well documented in histopathological studies. Nevertheless, cerebral vasculitis in later
stages of the Schistosoma mansoni infection have not yet been described in living subjects.
Case presentation: A 28-year-old french woman had a stroke linked with cerebral vasculitis, 6 monthes after
returning from Burkina-Faso. At the same time, a S. mansoni disseminated infection was diagnosed. She suffered
from a new stroke after undertaking praziquantel therapy, which lead us to associate the S. mansoni infection and
cerebral vasculitis.
Conclusion: This is the first report of such association, since cerebral vasculitis has never been described in later
stages of the S. mansoni infection. Although the causal link between the two pathologies could not be proved, we
suggest that S. mansoni is able to cause severe vascular damage in cerebral vessels. Schistosomiasis must be
investigated in the event of a brain infarct in young people, particularly in patients originating or returning from
an endemic area.
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Background
Schistosomiasis is a parasitic disease which remains a
public health problem in sub-Saharan Africa and South
America. More than 200 million people are affected by
it, and the disease continues to spread [1]. Schistosoma
mansoni infection needs percutaneous penetration of
cercariae, the non adult stage of the parasite. After a
short period of bloodstream circulation, the parasites
mature into mating pairs of male and female worms
which preferentially inhabit the inferior mesenteric
veins. Then, adult parasites are able to excrete the eggs.
Diagnosis could be done recovering Schistosoma eggs
from faeces or urine in the adult stage but not during
the invasive phase.For the latter, only a serologic test can
prove the infection.
In Europe, the disease is increasingly encountered
because of the increase in international travel and popu-
lation migration. Cerebral involvement in schistosomiasis
is not rare, but it is underdiagnosed because of the lack
of clinical suspicion and the frequency of asymptomatic
forms [2]. Neurologic complications generally occur in
the later stages of schistosomiasis and are supported by
granuloma formation around ectopic eggs which have
migrated to the brain. The host’s inflammatory reaction
probably plays an important role in explaining the great
clinical variation of neurologic forms. Deposition of ova
in the brain has been reported [3], and adult worms have
also been found in the spinal meningeal vein and intra-
cranial venous circulation [4]. The valveless perivertebral
Batson plexus seems to be preferential pathway of the
eggs and the adult worm to reach central nervous system.
Moreover, autopsic series have shown cerebral vascular
lesions in 20% of patients with S. mansoni infection [5].
In the invasive phase of schistosomiasis, neurologic
symptoms can also occur. In this acute stage known as
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Katayama fever, 2 to 6 weeks after contamination, neu-
rologic involvement is rare. In a large series of US sol-
diers returning from a Philippines campaign with acute
schistosomiasis, 2.3% of 1200 infected soldiers presented
neurologic symptoms [6]. In this early stage, hypereosi-
nophilia is pronounced and seems to be linked with cer-
ebral vasculitis [7]. Nevertheless, cerebral vasculitis in
later stages of infection without blood hypereosinophilia
have not yet been described in living subjects. We report
here a case of severe cerebral vasculitis in a 28-year-old
woman, associated with a later stage of S. mansoni infec-
tion, without hypereosinophilia. This is, to our knowl-
edge, the first report of such association in the literature.
Case presentation
A 28-year-old woman was admitted to the Neurovascu-
lar Unit for transient right hemiplegia associated with
language disorders, without fever. The patient com-
plained of unusual headaches since she had returned
from Burkina-Faso, 6 months before, where she had
worked for a humanitarian organization for one year.
She first had a cerebral Magnetic Resonance Imaging
(MRI) as soon as she returned to France, which failed to
show any disorder. She reported no illness during her
mission or before, but had frequently swum in a small
lake near where she lived. A cranial MRI was performed
at admission, showing multiple vascular hyperintense
signals in the left hemisphere. A day after admission,
as hemiplegia persisted, an angio-MRI was performed
which showed a left junctional infarct, straight stenosis
of the left carotid artery and inflammatory aspect of the
right carotid artery (Figure 1). No other big trunk was
involved on the complete aortic imaging, neither the
supra-aortic trunk nor the thoraco-abdominal portion of
aorta. Transoesophageal echocardiography did not show
any abnormalities. The physical examination showed no
hepatomegaly or splenomegaly. The vascular examination
found all the pulses. There were no symptoms of arthritis,
uveitis or skin manifestation. The white blood cell count
was normal, including the eosinophil count (300/mm3;
normal, < 500/mm3). C-reactive protein was normal. By
contrast, cerebrospinal fluid showed moderate lymphocy-
tic pleocytosis (28 cell/mm3) but without eosinophils. The
IgG index was elevated, although the protein concentra-
tion remained normal (0.28 gr/l; normal, < 0.50 gr/l).
Rheumatoid factor, Cryoglobulinemia, anti-cardiolipid,
anti-nuclear and anti-neutrophil cytoplasmic antibodies
were negative. Complement titer was elevated. Serologic
tests for Human Immunodeficiency Virus, Cytomegalo-
virus, Epstein-Barr-Virus and viral hepatitis B and C were
negative. The serologic test for schistosomiasis was
strongly positive in hemagglutination: 1/128 (normal,
< 1/8, in-house peparated antigen). Other helminthic
serologic tests were negative (trichinellosis, fasciolasis,
toxocariasis, anguillulosis). Repeated stool examinations
(Kato and Baermann method) failed to detect any
Schistosoma ova or other helminth ova. To substantiate
the diagnosis of disseminated schistosomiasis, a rectal
biopsy was performed, confirming the presence of
S. mansoni granuloma in rectal mucosa (Figure 2).
Treatment with anticoagulant and steroid therapy
(prednisone 1 mg/kg/day) was started immediately, with
rapid improvement of neurologic symptoms. A few days
later, a first-line course of praziquantel was given
(40 mg/kg/day for 3 days) and was well tolerated. Ten
days after admission, the patient was discharged from
hospital with oral anticoagulant therapy and prednisone
to be tapered progressively. One month later, a second
course of praziquantel was prescribed while she was still
taking prednisone at 20 mg/day. The day after she took
praziquantel, she complained of a headache and diplo-
pia. The neurologic examination showed right cranial
nerve VI paralysis. She was admitted to hospital and a
new angio-MRI revealed stenosis of the right carotid
siphon. Exacerbation of vasculitis after the praziquantel
therapy was suspected and intra-venous methylpredniso-
lone therapy was started (500 mg/day) with resolution of
diplopia within 24 h. Oral corticotherapy (1 mg/kg/day)
was prolonged for 6 weeks and progressively tapered.
The patient did not relapse when prednisone was dis-
continued. Anticoagulant therapy was maintained for a
longer period because of persistent carotid stenosis. A
new angio-MRI 6 months later showed minor improve-
ment of both carotid stenoses. The serologic level pro-
gressively decreased: 1/32 one year after the first
neurologic episode.
Discussion
Neuroschistosomiasis is an entity which has been thor-
oughly described in the literature. The spinal form is
Figure 1 Bilateral carotid vasculitis. Angio-MRI showing straight
stenosis of the left carotid artery and inflammatory aspect of the
right carotid artery (white arrows).
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more frequent than the cerebral form in S. mansoni
infection, probably because of the large size of
S. mansoni ova (150 μm long). In fact, the large size
of the ova and the lateral spine’s ability to block ova
progression along the Batson plexus and the vertebral
venous usually stops ascension to the brain [8].
Nevertheless, ova and even adult worms [9] can
sometimes reach the brain. Once ova are blocked,
they are able to cross the vascular wall and deposit
into medullary or cerebral parenchyma. At this time,
granuloma formation usually starts around them.
Moreover, S. mansoni ova can interact with endothe-
lial cells and provoke an inflammatory reaction
[10,11] leading to vascular damage, such as necrotiz-
ing vasculitis [12]. Thus, the pathophysiology of vas-
culitis in the latter stages of neuroschistosomiasis
(after onset of egg laying) can stem from the ability
of eggs to interact with endothelium and provoke an
inflammatory reaction in the vascular wall, decreasing
the vessel lumen and thrombosing. Host immunity
may explain why some people have an asymptomatic
form of neuroschistosomiasis [2]. On the other hand,
in the invasive stage, the pathophysiology is less clear
because the ova cannot be involved in the pathogen-
esis of vasculitis as they have not yet been laid.
Eosinophil-mediated toxicity has been suggested to
explain vasculitis and small-vessel thrombosis in acute
neuroschistosomiasis [7].
We describe here a case of stroke in a young woman
characterized by substantial vascular involvement at the
origin of junctional territory infarct. At the same time,
diagnosis of schistosomiasis is supported by both the
highly positive serologic test and S. mansoni ova found
in the rectal mucosa biopsy. We cannot exclude a pri-
mary angiitis of the central nervous system, but vascular
imagery usually shows alternating stenosis and narrow-
ings of blood vessels in this pathology [13], and such
findings were not present in our patient. Therefore, dif-
ferential diagnoses of carotid disease have to be dis-
cussed. In this case, we don't have any arguments for
auto-immune or Takayasu disease, cancer or lymphoma
after two years of follow-up.
A brain biopsy was not performed because of the high
risk and insufficient benefits in our opinion, so we are
unable to conclude wether there is a causal link between
schistosomiasis and carotid vasculitis. Nevertheless,
diplopia arose immediately after the second praziquantel
treatment which suggests that such a therapy contribu-
ted to an exacerbation of vasculitis, which was no longer
controlled by the low dose of prednisone. The immedi-
ate response to high-dose corticotherapy also argues in
favour of the inflammatory hypothesis.
Conclusion
We describe here a young woman who suffered from a
stroke linked with carotid vasculitis. At the same time, a
S. mansoni disseminated infection have been diagnosed.
This is the first report of such association, since caro-
tid vasculitis have never been described in later stages
of S. mansoni infection. Although the causal link
between the two pathologies could not be proved, we
suggest that S. mansoni is able to cause severe vascular
damage in cerebral vessels. This case report points
out the potential of severe vascular damage in
Figure 2 Rectal mucosa biopsy. Granuloma around a Shcistosoma mansoni egg (black arrow). Magnification X 400.
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neuroschistosomiasis, emphasizing the need to include
it in the differential diagnosis of cerebral vasculitis and
brain infarct in young people, particularly in patients
originating or returning from an endemic area. Corti-
cotherapy must always precede praziquantel when neu-
roschistosomiasis is suspected.
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